JP2022535401A5 - - Google Patents
Info
- Publication number
- JP2022535401A5 JP2022535401A5 JP2021571800A JP2021571800A JP2022535401A5 JP 2022535401 A5 JP2022535401 A5 JP 2022535401A5 JP 2021571800 A JP2021571800 A JP 2021571800A JP 2021571800 A JP2021571800 A JP 2021571800A JP 2022535401 A5 JP2022535401 A5 JP 2022535401A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024206717A JP2025027050A (ja) | 2019-06-03 | 2024-11-27 | アルカリホスファターゼ製剤及びその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962856309P | 2019-06-03 | 2019-06-03 | |
| US62/856,309 | 2019-06-03 | ||
| PCT/US2020/035814 WO2020247421A1 (en) | 2019-06-03 | 2020-06-03 | Alkaline phosphatase formulations and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024206717A Division JP2025027050A (ja) | 2019-06-03 | 2024-11-27 | アルカリホスファターゼ製剤及びその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022535401A JP2022535401A (ja) | 2022-08-08 |
| JP2022535401A5 true JP2022535401A5 (https=) | 2023-06-07 |
| JPWO2020247421A5 JPWO2020247421A5 (https=) | 2023-06-07 |
Family
ID=73653033
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021571800A Pending JP2022535401A (ja) | 2019-06-03 | 2020-06-03 | アルカリホスファターゼ製剤及びその使用 |
| JP2024206717A Pending JP2025027050A (ja) | 2019-06-03 | 2024-11-27 | アルカリホスファターゼ製剤及びその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024206717A Pending JP2025027050A (ja) | 2019-06-03 | 2024-11-27 | アルカリホスファターゼ製剤及びその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220323367A1 (https=) |
| EP (1) | EP3975999A4 (https=) |
| JP (2) | JP2022535401A (https=) |
| KR (1) | KR20220016199A (https=) |
| CN (2) | CN119896726A (https=) |
| AU (1) | AU2020287084B2 (https=) |
| CA (1) | CA3142240A1 (https=) |
| WO (1) | WO2020247421A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220005560A (ko) | 2019-05-06 | 2022-01-13 | 신세틱 바이오로직스, 인코퍼레이티드 | 알칼리성 포스페이트-기반 종양학 치료제 |
| KR20220111693A (ko) | 2019-12-09 | 2022-08-09 | 알렉시온 파마슈티칼스, 인코포레이티드 | 알칼리성 포스파타제 폴리펩티드 및 이의 이용 방법 |
| US12083169B2 (en) * | 2021-02-12 | 2024-09-10 | Alexion Pharmaceuticals, Inc. | Alkaline phosphatase polypeptides and methods of use thereof |
| WO2023141560A2 (en) * | 2022-01-20 | 2023-07-27 | Synthetic Biologics, Inc. | Alkaline phosphatase for use in oncology |
| US20260048103A1 (en) * | 2022-08-09 | 2026-02-19 | Theriva Biologics, Inc. | Treatment or prevention of gastrointestinal immunotherapy side effects |
| CN118216620A (zh) * | 2024-05-24 | 2024-06-21 | 中国农业科学院北京畜牧兽医研究所 | 牛碱性磷酸酶bIAP作为饲料添加剂用于抵抗产气荚膜梭菌感染肉鸡所致感染症状的应用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4537776A (en) | 1983-06-21 | 1985-08-27 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone |
| PT1355919E (pt) | 2000-12-12 | 2011-03-02 | Medimmune Llc | Moléculas com semivida longa, composições que as contêm e suas utilizações |
| US7048914B2 (en) | 2002-12-12 | 2006-05-23 | Zoltan Laboratories | Placental alkaline phosphatase to control diabetes |
| ES2280891T3 (es) * | 2003-12-04 | 2007-09-16 | F. Hoffmann-La Roche Ag | Metodo para obtener polinucleotidos circulares mutados y/o quimericos. |
| CA2554683C (en) * | 2004-02-04 | 2014-06-10 | Pharmaaware Sepsis B.V. | Use of alkaline phosphatase for the detoxification of lps present at mucosal barriers |
| WO2008001341A1 (en) * | 2006-06-27 | 2008-01-03 | Biovail Laboratories International Srl | Multiparticulate osmotic delivery system |
| US9023352B2 (en) | 2007-02-20 | 2015-05-05 | Tufts University | Methods, compositions and kits for treating a subject using a recombinant heteromultimeric neutralizing binding protein |
| EP1985697A1 (en) * | 2007-04-27 | 2008-10-29 | AM-Pharma B.V. | Modified phosphatases |
| WO2010025267A2 (en) | 2008-08-29 | 2010-03-04 | The General Hospital Corporation | Methods of modulating gastrointestinal tract flora levels with alkaline phosphatase |
| EP2570120B1 (en) * | 2010-06-08 | 2017-10-25 | Kobe Gakuin Educational Foundation | Coated particle and method for producing coated particle |
| KR101243938B1 (ko) * | 2010-10-19 | 2013-03-19 | 이희엽 | 타크롤리무스를 유효성분으로 함유하는 서방형 펠렛 |
| US20130251701A1 (en) | 2010-10-22 | 2013-09-26 | Zoltan Kiss Consulting | Alkaline phosphatase to correct insulin resistance, hyperinsulinemia, and dyslipidemia |
| CN102743339B (zh) * | 2012-07-20 | 2015-01-14 | 苏州大学 | 一种碱性磷酸酶纳微颗粒及其制备方法 |
| CA2899925A1 (en) | 2013-02-04 | 2014-08-07 | Seres Therapeutics, Inc. | Compositions and methods for inhibition of pathogenic bacterial growth |
| EP3125870A4 (en) | 2014-04-04 | 2017-12-13 | Alba Therapeutics Corporation | Methods of treating celiac disease with larazotide |
| RU2016138847A (ru) | 2014-04-07 | 2018-05-07 | Хэлф Ресерч, Инк. | Композиции и способы, относящиеся к покоящимся предрасположенным к старению клеткам (DSPC) |
| CN106890326A (zh) | 2015-12-21 | 2017-06-27 | 青岛黄海制药有限责任公司 | 一种含复合磷酸酯酶的肠溶微丸及其制备 |
| AU2017297718B2 (en) * | 2016-07-11 | 2023-06-08 | Contera Pharma A/S | Pulsatile drug delivery system for treating morning akinesia |
| WO2018175413A1 (en) * | 2017-03-21 | 2018-09-27 | Synthetic Biologics, Inc. | Alkaline phosphatase formulations |
| WO2019183208A1 (en) | 2018-03-20 | 2019-09-26 | Synthetic Biologics, Inc. | Intestinal alkaline phosphatase formulations |
-
2020
- 2020-06-03 US US17/615,942 patent/US20220323367A1/en active Pending
- 2020-06-03 AU AU2020287084A patent/AU2020287084B2/en active Active
- 2020-06-03 CA CA3142240A patent/CA3142240A1/en active Pending
- 2020-06-03 CN CN202411827248.5A patent/CN119896726A/zh active Pending
- 2020-06-03 WO PCT/US2020/035814 patent/WO2020247421A1/en not_active Ceased
- 2020-06-03 CN CN202080053704.9A patent/CN114222561A/zh active Pending
- 2020-06-03 JP JP2021571800A patent/JP2022535401A/ja active Pending
- 2020-06-03 EP EP20818286.5A patent/EP3975999A4/en active Pending
- 2020-06-03 KR KR1020217043142A patent/KR20220016199A/ko active Pending
-
2024
- 2024-11-27 JP JP2024206717A patent/JP2025027050A/ja active Pending